Stocks and Investing Stocks and Investing
Mon, July 1, 2024

Josh Schimmer Reiterated (BBIO) at Buy and Held Target at $70 on, Jul 1st, 2024


Published on 2024-10-28 12:11:23 - WOPRAI, Josh Schimmer
  Print publication without navigation


Josh Schimmer of Cantor Fitzgerald, Reiterated "BridgeBio Pharma, Inc." (BBIO) at Buy and Held Target at $70 on, Jul 1st, 2024.

Josh has made no other calls on BBIO in the last 4 months.



There are 6 other peers that have a rating on BBIO. Out of the 6 peers that are also analyzing BBIO, 0 agree with Josh's Rating of Hold.



These are the ratings of the 6 analyists that currently disagree with Josh


  • Geoff Meacham of "B of A Securities" Maintained at Strong Buy with Decreased Target to $42 on, Tuesday, June 25th, 2024
  • Raghuram Selvaraju of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $43 on, Thursday, June 20th, 2024
  • Eliana Merle of "UBS" Maintained at Strong Buy with Decreased Target to $47 on, Tuesday, May 28th, 2024
  • Cory Kasimov of "Evercore ISI Group" Initiated at Buy and Held Target at $50 on, Tuesday, May 14th, 2024
  • Anupam Rama of "JP Morgan" Maintained at Buy with Increased Target to $45 on, Wednesday, March 20th, 2024
  • Salim Syed of "Mizuho" Maintained at Strong Buy with Decreased Target to $53 on, Tuesday, March 5th, 2024
Contributing Sources